Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool	Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Active, not recruiting	Not stated	2026-05-15		NCT06550037

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Accare	5
Alessio Fasano	1
ARTIFICIAL INTELLIGENCE EXPERT SRL	1
Biokeralty Research Institute	2
CEINGE	1
Cephalgo	1
Fondazione di ricerca biomedica EBRIS	1
Fundació Eurecat	9
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta	15
Istanbul Medipol University Hospital	61
Mama Health Technologies GmbH	1
Perseus Biomics	1
Protobios OU	1
Sanitas University	2
University of Siena	20

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Università Degli Studi Di Siena	Siena	Italy	1